ADAGE CAPITAL PARTNERS GP LLC 13D and 13G filings for Akero Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-07 07:23 am Sale |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
ADAGE CAPITAL PARTNERS GP LLC | 275,000 0.490% |
-2,527,627 (-90.19%) |
Filing |
| 2023-04-10 4:59 pm Purchase |
2023-03-30 | 13G | Akero Therapeutics, Inc. AKRO |
ADAGE CAPITAL PARTNERS GP LLC | 2,802,627 5.970% |
2,802,627 (New Position) |
Filing |